How AI and big data are shaping the future of sales in pharma
Technology plays an essential role in how pharmaceutical firms conduct business in today’s digitally influenced world.
Technology plays an essential role in how pharmaceutical firms conduct business in today’s digitally influenced world.
A recent run of high-profile cyberattacks has highlighted the need for healthcare organisations to invest in continuing security initiatives.
According to research published in Cancer, medication mistakes are widespread in children with leukaemia or lymphoma, and these errors can cause substantial injury.
Fifteen key players from the UK’s £73 billion chemicals and pharmaceuticals sector have signed an agreement to launch Flue2Chem, a program aimed at transforming the sustainability of the UK’s consumer products industry and reducing greenhouse gas emissions.
Pfizer has announced a label expansion for its breast cancer drug, Ibrance, after the FDA extended its approval.
The FDA has approved a new regulation requiring pharmaceutical producers to include a bar code on all immediate-release medicine packages.
XRP Healthcare is developing a decentralised pharmaceutical marketplace that will operate independently of central banking institutions.
Bayer anticipated that their experimental blood clot drug might generate more than 5 billion euros ($5.4 billion) in peak annual sales.
By publishing key bioequivalence results on a prospect created to increase adherence to treatment regimens for kidney illness, Unicycive Therapeutics has paved the way for entering a space pursued by Sanofi and Takeda.
The FDA rejected UCB’s much awaited psoriasis treatment bimekizumab as a result of problems with facility inspections, therefore the firm is now praising the medicine’s potential in a different use.
Technology plays an essential role in how pharmaceutical firms conduct business in today’s digitally influenced world.
A recent run of high-profile cyberattacks has highlighted the need for healthcare organisations to invest in continuing security initiatives.
According to research published in Cancer, medication mistakes are widespread in children with leukaemia or lymphoma, and these errors can cause substantial injury.
Fifteen key players from the UK’s £73 billion chemicals and pharmaceuticals sector have signed an agreement to launch Flue2Chem, a program aimed at transforming the sustainability of the UK’s consumer products industry and reducing greenhouse gas emissions.
Pfizer has announced a label expansion for its breast cancer drug, Ibrance, after the FDA extended its approval.
The FDA has approved a new regulation requiring pharmaceutical producers to include a bar code on all immediate-release medicine packages.
XRP Healthcare is developing a decentralised pharmaceutical marketplace that will operate independently of central banking institutions.
Bayer anticipated that their experimental blood clot drug might generate more than 5 billion euros ($5.4 billion) in peak annual sales.
By publishing key bioequivalence results on a prospect created to increase adherence to treatment regimens for kidney illness, Unicycive Therapeutics has paved the way for entering a space pursued by Sanofi and Takeda.
The FDA rejected UCB’s much awaited psoriasis treatment bimekizumab as a result of problems with facility inspections, therefore the firm is now praising the medicine’s potential in a different use.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.